Cannabis Movers & Shakers: Leafly Holdings, Linneo Health, Flowhub, MindMed
Leafly Holdings Taps Suresh Krishnaswamy As New CFO
Psychedelic Front Runners MindMed , BioXcel Patent System To Identify Agitation
This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission.
COVID Tests, THC Patches, Psychedelics: Xphyto Therapeutics Does it All
Image by Shameer Pk from Pixabay
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
This article by Jason Najum was originally published on Microdose Psychedelic Insights and appears here with permission.
The psychedelic medicine industry continues to get attention and gain credibility in the investment world.
From BZ’s Small Cap Healthcare Conference: MinMed CEO, Robert Barrow Begins Speaking
Click To Tune In Here... youtube.com/watch?v=TG5SSZDlpBo
4 Stocks Disrupting Mental Health To Keep An Eye On At Benzinga’s Healthcare Conference
The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth.
Digital Therapeutics And The Future Of Psychedelic Medicine
Digital health and therapeutics will play a crucial role in the future of medicine. Across medical and mental health industries, companies are realizing that the confluence of healthcare and digital platforms will be part of the future of medicine.
‘Italian Referendum To Decriminalize Marijuana, Psilocybin And Other Drug Plants Gets Half A Million Signatures’ -Marijuana Moment
https://www.marijuanamoment.net/italian-referendum-to-decriminalize-marijuana-psilocybin-and-other-drug-plants-gets-half-a-million-signatures/
Compass: Psychedelics Unicorn Expands Portfolio Beyond Psilocybin Into Psychedelics 2.0
Psychedelics biotech company Compass Pathways (NASDAQ: CMPS) has purchased an intellectual property portfolio that includes patent applications for a variety of psychedelic and empathogenic substances.